Data Worldwide: Health

Global Health Observatory (GHO) (United Nations World Health Organization)

Below is a list of almost 1000 health-related indicators for which data are available from the Global Health Observatory of the World Health Organization. Data are usually available for all countries of the world and many recent years or periods. However, for some indicators only few data points are available. Click the indicator name to access the data from WHO.

Ambient air pollution attributable deaths
Ambient air pollution attributable DALYs per 100'000 children under 5 years
Household air pollution attributable deaths
Household air pollution attributable deaths in children under 5 years
Household air pollution attributable deaths per 100'000 capita
Household air pollution attributable deaths per 100'000 children under 5 years
Household air pollution attributable DALYs ('000) in children under 5 years
Household air pollution attributable DALYs per 100'000 children under 5 years
Population using electricity as main cooking fuel (%)
Ambient air pollution (Annual PM10 [ug/m3])
Population using LPG as main cooking fuel (%)
Population using natural gas as main cooking fuel (%)
Population using biogas as main cooking fuel (%)
Population using kerosene as main cooking fuel (%)
Population using clean fuels (sum of)(%)
Population using coal as main cooking fuel (%)
Population using charcoal as main cooking fuel (%)
Population using wood as main cooking fuel (%)
Population using dung as main cooking fuel (%)
Population using crop waste as main cooking fuel (%)
Percentage of the total population living in cities > 100'000 inhabitants
Population using solid fuels (sum of) (%)
Population using others (non listed items) as main cooking fuel (%)
Population not cooking (%)
Missing information on cooking fuels (%)
Total survey respondents
Joint effects of air pollution attributable deaths
Joint effects of air pollution attributable deaths in children under 5 years
Joint effects of air pollution attributable deaths per 100'000 capita
Joint effects of air pollution attributable deaths per 100'000 children under 5 years
Ambient air pollution attributable deaths in children under 5 years
Ambient air pollution attributable deaths per 100'000 capita
Ambient air pollution attributable deaths per 100'000 children under 5 years
Ambient air pollution attributable DALYs ('000)
Ambient air pollution attributable DALYs ('000) in children under 5 years
Ambient air pollution attributable DALYs per 100'000 capita
Raised blood pressure (SBP≥140 OR DBP≥90 OR on medication) (crude estimate)
Raised blood pressure (SBP≥140 OR DBP≥90 OR on medication) (age-standardized estimate)
Raised blood pressure (SBP≥140 OR DBP≥90) (crude estimate)
Raised blood pressure (SBP≥140 OR DBP≥90) (age-standardized estimate)
Mean systolic blood pressure (crude estimate)
Mean systolic blood pressure (age-standardized estimate)
Climate change attributable deaths
Climate change attributable DALYs ('000)
Climate change attributable deaths per 100'000 capita
Climate change attributable DALYs per 100'000 capita
Climate change attributable deaths ('000) in children under 5 years
Climate change attributable deaths per 100'000 children under 5 years
Climate change attributable DALYs ('000) in children under 5 years
Climate change attributable DALYs per 100'000 children under 5 years
Number of reported cases of cholera
Number of reported deaths from cholera
Cholera case fatality rate
Raised total cholesterol (≥ 5.0 mmol/L) (crude estimate)
Raised total cholesterol (≥ 5.0 mmol/L) (age-standardized estimate)
Mean Total Cholesterol (age-standardized estimate)
Mean Total Cholesterol (crude estimate)
Raised total cholesterol (≥ 6.2 mmol/L) (age-standardized estimate)
Raised total cholesterol (≥ 6.2 mmol/L) (crude estimate)
Number of under-five deaths (thousands)
Number of infant deaths (thousands)
Number of neonatal deaths (thousands)
Process evaluation was employed to assess implementation
Formative research was conducted
Outcome evaluation was employed to assess effectiveness
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Campaign utilized media planning
At least one national mass media campaign ran during the survey period
Earned media/public relations were used to promote the campaign
Total density per 100 000 population: Health posts
Total density per 100 000 population: Health centres
Total density per 100 000 population: District/rural hospitals
Total density per 100 000 population: Provincial hospitals
Total density per 100 000 population: Specialized hospitals
Availability of national standards or recommended lists of medical devices
Types of lists recommending health technology for high burden diseases
Total density per million population: Magnetic Resonance Imaging
Total density per million population: Computed tomography units
Total density per million population: Positron Emission tomography
Total density per million population: Gamma camera or Nuclear medicine
Total density per million population: Linear Accelerator
Type of nomenclature system
Use of nomenclature system
Health technology (medical device) national policy
Unit in the Ministry of Health responsible for the management of medical devices
Procurement of medical devices carried out at the national level
Availability of national list of approved medical devices for procurement or reimbursement
National guidelines, policies or recommendations on the procurement of medical devices
Availability of technical specifications of medical devices to support procurement or donations
Total density per million population: Telecobalt Unit
Total density per million population: Radiotherapy units
Total density per million females aged from 50 to 69 years old: Mammography units
Promotional discounts
Non-tobacco products identified with tobacco brand names
Brand name of non-tobacco products used for tobacco product
Ban on appearance of tobacco brands in TV and/or films (product placement)
Appearance of tobacco products in TV and/or films
Sponsored events
National television and radio
Subnational bans on tobacco advertising, promotion and sponsorship
International television and radio
Local magazines and newspapers
International magazines and newspapers
Billboard and outdoor advertising
Point of sale
Internet
Free distribution in mail or through other means
Compliance with bans on direct advertising
Compliance with bans on promotion and sponsorship
Coverage of antenatal care (4 visits)
Prevalence of obesity among women
Coverage of DTP3 immunization
HIV prevalence
Knowlege about sexual transmission of AIDS
Coverage of measles immunization
Coverage of skilled birth attendance
Prevalence of current cigarette smoking
Slum population in urban areas (% of total population)
Population using improved drinking-water sources (%)
Enforce bans on tobacco advertising
Age-standardized death rates (per 100 000 population)
Disability-adjusted life years (DALYs) (per 100 000 population)
Disability-adjusted life years (DALYs) (in thousands)
Years of healthy life lost due to disability (YLDs) (in thousands)
Years of healthy life lost due to disability (YLDs) (per 100 000 population)
Years of life lost from mortality (YLLs) (in thousands)
Years of life lost from mortality (YLLs) (per 100 000 population)
Number of people (all ages) living with HIV
Number of adults aged 15 and over living with HIV
Number of women aged 15 and over living with HIV
Number of children under 15 living with HIV
Number of deaths due to HIV/AIDS
Testing and counselling facilities, reported number
Testing and counselling facilities, estimated number per 100 000 adult population
Reported number of people receiving antiretroviral therapy
Reported number of people receiving antiretroviral therapy, month and year of report
Reported number of children receiving antiretroviral therapy
Pregnant women tested for HIV, reported number
Pregnant women tested for HIV, estimated coverage (%)
Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period
Number of people aged 15 years and over who received HIV testing and counselling, reported number
People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population
Number of people aged 15 years and over who received HIV testing and counselling, reporting period
Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on UNAIDS/WHO methods
Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
Estimated number of children needing antiretroviral therapy based on UNAIDS/WHO methods
Estimated antiretroviral therapy coverage among children
Number of under-five deaths from HIV/AIDS
Number of adults and children newly infected with HIV
Number of nursing personnel
Number of physicians
Number of midwifery personnel
Number of pharmacists
Number of pharmaceutical technicians/assistants
Number of community health workers
Number of traditional birth attendants
Number of radiographers
Number of dental technicians/assistants
Number of health management & support workers
Number of environment and public health workers
Number of laboratory scientists
Number of laboratory technicians/assistants
Number of dentists
Number of traditional medicine practitioners
Number of medical assistants
Number of personal care workers
Number of pharmaceutical personnel
Number of laboratory health workers
Number of dentistry personnel
Number of community and traditional health workers
Number of other health workers
Number of nursing and midwifery personnel
Pharmaceutical personnel density (per 1000 population)
Physicians density (per 1000 population)
Laboratory health workers density (per 1000 population)
Dentistry personnel density density (per 1000 population)
Community and traditional health workers density (per 1000 population)
Other health workers density (per 1000 population)
Environmental and public health workers density (per 1000 population)
Health management & support workers density (per 1000 population)
Nursing and midwifery personnel density (per 1000 population)
Handwashing with soap after using the toilet (%)
Handwashing with soap after cleaning child's stool (%)
Legislation
Coordination
Surveillance
Response
Preparedness
Risk communication
Human resources
Laboratory
Points of entry
Zoonosis
Food safety
Chemical
Radionuclear
Percentage of the children under 15 years with blood lead levels above 5ug/dl
Lead attributable DALYs per 100'000 children under 5 years
Percentage of the children under 15 years with blood lead levels above 10ug/dl
Percentage of the adults (15+ years) with blood lead levels above 5ug/dl
Percentage of the adults (15+ years) with blood lead levels above 10ug/dl
Lead attributable deaths
Lead attributable DALYs ('000)
Lead attributable deaths per 100'000 capita
Lead attributable DALYs per 100'000 capita
Lead attributable DALYs ('000) in children under 5 years
nMx - age-specific death rate between ages x and x+n
nqx - probability of dying between ages x and x+n
lx - number of people left alive at age x
ndx - number of people dying between ages x and x+n
nLx - person-years lived between ages x and x+n
Tx - person-years lived above age x
ex - expectation of life at age x
Malaria - number of reported deaths
Estimated number of malaria cases
Estimated number of malaria deaths
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Adolescent fertility rate (per 1000 girls aged 15-19 years)
Contraceptive prevalence (%)
Contraceptive prevalence, among girls aged 15-19 (%)
Unmet need for family planning (%)
Unmet need for family planning, among girls aged 15-19 (%)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Median availability of selected generic medicines (%) - Public
Median consumer price ratio of selected generic medicines - Public
Children aged <5 years sleeping under insecticide-treated nets (%)
Children aged <5 years with fever who received treatment with any antimalarial (%)
Prevalence of condom use by adults during higher-risk sex (15-49) (%)
Deaths due to malaria (per 100 000 population)
Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
Incidence of tuberculosis (per 100 000 population per year)
Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)
Prevalence of tuberculosis (per 100 000 population)
Births attended by skilled health personnel (%)
Births attended by skilled health personnel, among girls aged 15-19 (%)
Maternal mortality ratio (per 100 000 live births) - Interagency estimates
Children aged <5 years stunted (%)
Prevalence of HIV among adults aged 15 to 49 (%)
Smear-positive tuberculosis treatment-success rate (%)
Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
Number of suspected meningitis deaths reported
Number of suspected meningitis cases reported
Number of meningitis epidemic districts
Mental health policy
Mental health outpatient facilities (per 100,000)
Mental health day treatment facilities (per 100,000)
Beds for mental health in general hospitals (per 100,000)
Community residential facilities (per 100,000)
Beds in community residential facilities (per 100,000)
Beds in mental hospitals (per 100,000)
Mental hospitals (per 100,000)
Mental health plan
Mental health legislation
Government expenditures on mental health as a percentage of total government expenditures on health (%)
Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
Psychiatrists working in mental health sector (per 100,000)
Nurses working in mental health sector (per 100,000)
Social workers working in mental health sector (per 100,000)
Psychologists working in mental health sector (per 100,000)
Number of deaths
Deaths per 1 000 live births
Distribution of causes of death among children aged < 5 years (%)
Deaths per 100 000 population
Number of deaths
Projection of number of deaths
Projection of deaths per 100 000 population
Current smoking of cigarettes (age-standardized rate)
Daily smoking of cigarettes (age-standardized rate)
Current smoking of any tobacco product (age-standardized rate)
Daily smoking of any tobacco product (age-standardized rate)
Monitor
Adult indicator 1 rate
Adult indicator 1 definition
Adult indicator 2 rate
Adult indicator 2 definition
Representativeness of survey of adults
Representativeness of youth survey
Year of survey of adults
Probability (%) of dying between exact ages 30 and 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
BMI ≥ 25 (age-standardized estimate)
BMI ≥ 25 (crude estimate)
BMI ≥ 30 (age-standardized estimate)
BMI ≥ 30 (crude estimate)
Mean BMI (kg/m2) (age-standardized estimate)
Mean BMI (kg/m2) (crude estimate)
Cancers, deaths per 100,000 (age-standardized estimate)
Cardiovascular diseases and diabetes, deaths per 100,000 (age-standardized estimate)
General availability of ACE inhibitors in the public health sector
General availability of acetic acid visualization at the primary health care level
Existence of operational policy/strategy/action plan for alcohol
General availability of aspirin (100 mg) in the public health sector
General availability of beta blockers in the public health sector
General availability of bowel cancer screening (by digital exam or colonoscopy) at the primary health care level
General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
General availability of CC blockers in the public health sector
Existence of operational policy/strategy/action plan for diabetes
Existence of operational policy/strategy/action plan for cardiovascular diseases
Existence of operational policy/strategy/action plan for cancer
Existence and scope of cancer registry
General availability of cervical cytology at the primary health care level
General availability of chemotherapy in the public health system
General availability of total cholesterol measurement at the primary health care level
Existence of partnerships/collaborations for implementing key activities related to NCDs
Availability and stage of implementation of guidelines/protocols/standards for the management of diabetes
Existence of operational policy/strategy/action plan for chronic respiratory diseases
General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
Existence of operational policy/strategy/action plan for unhealthy diet and/or overweight/obesity
Earmarking of taxes from fiscal interventions to influence behaviour change used to fund health promotion programmes or a health promotion foundation
General availability of electrocardiogram at the primary health care level
General availability of glibenclamide in the public health sector
General availability of hydrocortisone injections in the public health sector
Availability and stage of implementation of guidelines/protocols/standards for the management of raised blood pressure / hypertension
General availability of insulin in the public health sector
General availability of ipratropium bromide in the public health sector
General availability of metformin in the public health sector
Existence of Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
General availability of nicotine patches or gums in the public health sector
General availability of oral morphine in the public health sector
Existence of operational policy/strategy/action plan for insufficient physical activity
General availability of prednisolone tabs in the public health sector
Existence of risk factor surveillance for selected risk factors (harmful alcohol use, diet, physical inactivity, and tobacco use)
General availability of radiotherapy in the public health system
General availability of renal replacement therapy (by dialysis or transplantation) in the public health system
General availability of retinal photocoagulation in the public health system
General availability of salbutamol in the public health sector
General availability of peak flow measurement spirometry at the primary health care level
General availability of statins in the public health sector
General availability of steroid inhalers in the public health sector
General availability of tamoxifen in the public health sector
Implementation of fiscal interventions to influence behaviour change
General availability of thiazide diuretics in the public health sector
Existence of operational policy/strategy/action plan for tobacco
Chronic respiratory diseases, deaths per 100,000 (age-standardized estimate)
All NCDs, deaths per 100,000 (age-standardized estimate)
Total NCD Deaths
Mean fasting blood glucose (mmol/l) (age-standardized estimate)
Mean fasting blood glucose (mmol/l) (crude estimate)
Raised fasting blood glucose (≥ 7.0 mmol/L or on medication) (crude estimate)
Raised fasting blood glucose (≥ 7.0 mmol/L or on medication)(age-standardized estimate)
Insufficiently active (age-standardized estimate)
Insufficiently active (crude estimate)
NCD deaths under age 60 (percent of all NCD deaths)
NCD deaths under age 70 (percent of all NCD deaths)
Basis for NHA estimate
Number of full-time equivalent staff in national agency
National agency for tobacco control exists
Annual budget for tobacco control in US$ at official exchange rate
Reported currency
Annual budget for tobacco control in currency reported
Government objectives on tobacco control exist
Budget year
Number of new reported cases of Buruli ulcer
Dracunculiasis certification status of countries at the beginning of the year
Number of new reported cases of human African trypanosomiasis (T.b. gambiense)
Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)
Status of endemicity for blinding trachoma
Population living in trachoma endemic areas
Population treated for active trachoma
Status of endemicity of cutaneous leishmaniasis
Number of cases of cutaneous leishmaniasis reported
Status of endemicity of visceral leishmaniasis
Number of cases of visceral leishmaniasis reported
Status of yaws endemicity
Number of cases of yaws reported
Overweight numbers (in millions)
Overweight prevalence
Children aged <5 years wasted for age (%)
Stunting numbers (in millions)
Stunting prevalence
Underweight numbers (in millions)
Underweight prevalence
Occupational carcinogens attributable DALYs ('000)
Occupational carcinogens attributable deaths per 100'000 capita
Occupational carcinogens attributable DALYs per 100'000 capita
Occupational noise attributable DALYs ('000)
Occupational noise attributable DALYs per 100'000 capita
Occupational ergonomic stressors attributable deaths
Occupational ergonomic stressors attributable DALYs ('000)
Occupational ergonomic stressors attributable deaths per 100'000 capita
Occupational ergonomic stressors attributable DALYs per 100'000 capita
Occupational injuries attributable deaths
Occupational injuries attributable DALYs ('000)
Occupational injuries attributable deaths per 100'000 capita
Occupational injuries attributable DALYs per 100'000 capita
Occupational airborne particulates attributable deaths
Occupational airborne particulates attributable DALYs ('000)
Occupational airborne particulates attributable deaths per 100'000 capita
Occupational airborne particulates attributable DALYs per 100'000 capita
Occupational carcinogens attributable deaths
Donor commitments (Million, constant 2009 US$)
Commitments to recipient countries (Million, constant 2009 US$)
Donor disbursements (Million, constant 2009 US$)
Disbursements to recipient countries (Million, constant 2009 US$)
Treatment for tobacco dependence available in the community
Treatment for tobacco dependence available in health clinics or other primary care facilities
Treatment for tobacco dependence available in hospitals
Treatment for tobacco dependence available in offices of health professionals
Treatment for tobacco dependence available in other settings
Bupropion - legally sold
Bupropion - place available
Offer help to quit tobacco use
Nicotine replacement therapy - legally sold
Nicotine replacement therapy - place available
Access to a toll-free quit line
Varenicline - legally sold
Varenicline - place available
Subnational smoke-free legislation authority exists
Fines for violations
Fines on the establishment
Fines on the patron
Dedicated funds for enforcement
Citizen complaints and investigations
Comprehensive bans in place subnationally
Health-care facilities (national legislation)
Education facilities except universities (national legislation)
Universities (national legislation)
Government facilities (national legislation)
Indoor offices (national legislation)
Restaurants (national legislation)
Pubs and bars (national legislation)
Public transport (national legislation)
All other indoor public places (national legislation)
Compliance with regulations on smoke-free environments (national legislation)
Protect from tobacco smoke
Number of places smoke-free (national legislation)
Antenatal care attendees who were positive for syphilis (%)
Men who have sex with men (MSM) with active syphilis (%)
Sex workers with active syphilis (%)
Antenatal care (ANC) attendees tested for syphilis at first ANC visit (%)
Antenatal care attendees positive for syphilis who received treatment (%)
Intimate partner violence prevalence among ever partnered women (%)
Non-partner sexual violence prevalence (%)
Point prevalence (%), alcohol use disorders, 15+ years
National survey on substance use among children and adolescents
Data on substance use disorders disseminated in national annual reports
Substance use policy at the national level
Substance use policy at the national level, level of integration
Policy documents on the pharmacological treatment of substance use disorders
Guidelines on the pharmacological treatment of substance use disorders
Legislative provision for treatment and rehabilitation of substance use disorders
Legislative provision for compulsory treatment
Drug courts
Programmes diverting clients from the justice system towards treatment
Point prevalence (%), drug use disorders, 15+ years
Confidentiality of health records on substance use disorders protected by law
Government unit for substance use disorder treatment
Budget line for substance use disorder treatment
Financing method for substance use disorder treatment
Government benefits for persons with substance use disorders
Government benefits for alcohol use disorders, subsidy or disability pension
Government benefits for drug use disorders, subsidy or disability pension
Sector for inpatient detoxification of alcohol use disorders
Age-standardized death rates, alcohol and drug use disorders, per 100 000
Sector for inpatient treatment of alcohol dependence
Sector for outpatient treatment of alcohol dependence
Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
Sector for residential long-term rehabilitation of alcohol use disorders
Sector for inpatient detoxification of drug use disorders
Sector for inpatient treatment of drug dependence
Sector for outpatient treatment of drug dependence
Sector for substitution maintenance therapy of opioid dependence
Sector for residential long-term rehabilitation of drug use disorders
Treatment system for substance use disorders
Treatment setting for substance use disorders, most common
Specialized treatment services for drug use disoders and HIV/AIDS
Specialized treatment services for substance use disorders and TB
Open access services for substance use disorders
Treatment slots for alcohol and drug use disorders, outpatient, per 10 000
Beds for the treatment of substance use disorders, per 100 000
Length of stay for inpatient detoxification, days
Length of stay for inpatient short-term treatment, days
Length of stay for inpatient long-term residential treatment, days
Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
Age-standardized DALYs, alcohol and drug use disorders, per 100 000
Timeframe of opioid agonist treatment
Methadone used for the treatment of opioid dependence
Methadone used for detoxification or maintenance
Methadone formulation used for the treatment of opiod dependence
Buprenorphine used for the treatment of opioid dependence
Buprenorphine used for detoxification or maintenance
Buprenorphine/naloxone used for detoxification or maintenance
Methadone provision in clinical and community-based settings
Buprenorphine provision in clinical and community-based settings
Buprenorphine/naloxone provision in clinical and community-based settings
Supervision requirements for methadone administration
Supervision requirements for buprenorphine administration
Supervision requirements for buprenorphine/naloxone administration
Prescription requirements for methadone
Prescription requirements for buprenorphine
Prescription requirements for buprenorphine/naloxone
Commencement of treatment with opioid agonists
Pharmacotherapy used for the management of alcohol withdrawal
Pharmacotherapy used for the management of benzodiazepine withdrawal
Psychoactive substance causing entry into treatment
Pharmacotherapy used for the management of cannabis withdrawal
Essential list of medicines
Essential list of medicines, pharmacotherapy for substance use disorders
Government unit for substance use disorder prevention
Budget line for substance use disorder prevention
Funding method for substance use disorder prevention
Prevention activities for substance use disorders, main focus
Programmes for the prevention of substance use disorders for special populations
Screening and brief interventions for substance use and substance use disorders
Harm reduction programmes for IDUs
Epidemiological data collection system for substance use disorders
Health professionals mostly involved in treatment of substance use disorders
Clinical supervision of health care staff
Standards of care for health professionals
Standards of care for health professionals, maintenance
Standards of care for health professionals, human rights
NGOs for alcohol use disorders
NGOs for drug use disorders
Self-help groups for substance use disorders
Groups and agencies for the prevention of substance use disorders
Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
Service delivery data collection system for substance use disorders
Population
Income level
Number of registered vehicles
Estimated number of road traffic deaths
Estimated road traffic death rate (per 100 000 population)
Existence of a national drink-driving law
Definition of drink-driving by BAC
Blood Alcohol Concentration (BAC) limit for drivers
Attribution of road traffic deaths to alcohol (%)
Existence of a national seat-belt law
Applicability of seat-belt law to all occupants
Seat-belt wearing rate (%)
Existence of a national child-restraint law
Existence of national speed limits
Adaptation of national speed limit at a local level
Maximum speed limits
Existence of a national motorcycle helmet law
Applicability of national motorcycle helmet law to all occupants
Applicability of national motorcycle helmet law to all road types
Applicability of national motorcycle helmet law to all engine types
Requirement of motorcycle helmet use to adhere to standard
Motorcycle helmet wearing rate (%)
Existence of a road safety lead agency
Existence of a national road safety strategy
Availability of funding for national road safety strategy
Existence of a national policy on walking and cycling
Existence of a national policy on public transport
Existence of road safety audit for all new roads
Existence of road safety audit for existing roads
Existence of a universal access telephone number for pre-hospital care
Estimated % of seriously injured patients transported by ambulance
Training in medical emergency - available for doctors
Training in medical emergency - available for nurses
Distribution of road traffic deaths by type of road user (%)
Gross national income per capita (Atlas method)
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Cheapest brand of cigarettes - currency reported
Most sold brand of cigarettes - currency reported
Raise taxes on tobacco
Most sold brand of cigarettes - taxes as a % of price - other taxes
Cheapest brand of cigarettes - price in currency reported
Cheapest brand of cigarettes - price in international dollars
Cheapest brand of cigarettes - price in US$ at official exchange rates
Most sold brand of cigarettes - price in currency reported
Most sold brand of cigarettes - price in international dollars
Most sold brand of cigarettes - price in US$ at official exchange rates
Most sold brand of cigarettes - taxes as a % of price - specific excise
Most sold brand of cigarettes - taxes as a % of price - value added tax
Tobacco excises increased over the survey period
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - total tax
Consumption of pure alcohol by type of beverage (%)
Recorded alcohol per capita (15+) consumption (in liters of pure alcohol)
Recorded alcohol per capita (15+) consumption (in liters of pure alcohol), three-year average
Estimate of five-year change in recorded alcohol per capita (15+) consumption
Total (recorded three-year average + unrecorded) per capita (15+) consumption (in liters of pure alcohol)
Drinkers only, total (recorded three-year average + unrecorded) per capita (15+) consumption (in liters of pure alcohol)
Tourist consumption (in liters of pure alcohol)
Unrecorded alcohol per capita (15+) consumption (in liters of pure alcohol)
Abstainers, lifetime (%)
Abstainers, past 12 months (%)
Alcohol consumers (%), past 12 months
Former drinkers (%)
Heavy episodic drinking (population) past 30 days (%)
Heavy episodic drinking (drinkers only), past 30 days (%)
Patterns of drinking score
Alcohol dependence (15+), 12 month prevalence (%) with 95%CI
Alcohol use disorders (15+), 12 month prevalence (%) with 95%CI
Alcoholic beverage tax revenue as a per cent of government revenue
Annual revenues from alcohol excise tax in millions US$
Alcohol expenditure as a per cent of total household expenditure
Social costs of alcohol use in millions US$
Adopted written national policy on alcohol
Alcoholic beverage legally defined
Alcohol use is banned
National legislation to prevent illegal alcohol
Advertising restrictions on national television
Advertising restrictions on cable television
Advertising restrictions on national radio
Advertising restrictions on local radio
Advertising restrictions in print media
Advertising restrictions at cinemas
Advertising restrictions on billboards
Advertising restrictions at point-of-sale
Advertising restrictions on the internet
Restrictions on product placement on national television
Restrictions on product placement on cable television
Age limits on-premise service
Legal blood alcohol concentration (BAC) limits
Random breath testing (RBT) use
Average prices in US$
Off-premise sales restrictions on days
Off-premise sales restrictions on hours
Off-premise sales restrictions on places
Off-premise sales restrictions on outlet density
Off-premise sales restrictions at specific events
Off-premise sales restrictions at petrol stations
On-premise sales restrictions on days
On-premise sales restrictions on hours
On-premise sales restrictions on places
On-premise sales restrictions on outlet density
On-premise sales restrictions at specific events
On-premise sales restrictions to intoxicated persons
Restrictions on sponsorship of sporting events
Restrictions on sponsorship of youth events
Restrictions on sales promotion from producers (parties, events)
Restrictions on sales promotion from retailers (sales below cost)
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Government monopoly on production
Government monopoly on retail sales
Licence required for production
Licence required for retail sales
Excise tax as a per cent of the retail price of alcoholic beverages
Excise duty (average) per hectolitre in Euros
Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
Duty paid or excise stamp on alcohol container
Excise tax on alcoholic beverages
Value-added tax (VAT) on alcohol
Restrictions on alcohol use in public places
Health warning labels on alcohol advertising
Health warning labels on alcohol containers
Awareness activities
National drinking guidelines
Standard drink measures, in grams per unit
Total (recorded + unrecorded) adult (15+ years) per capita consumption, projected estimates for 2008
Central coordinating entity for alcohol policy implementation
Framework of national alcohol policy
Level of adoption of national alcohol policy
Sectors represented in national alcohol policy
Adopted written national policy on alcohol, year adopted
Adopted written national policy on alcohol, year revised
Age limits off-premise sales
Consumer information on alcohol and health at points of sale
Educational programmes involving target groups in school curriculum
Brief interventions as health promotion/disease prevention
Server training on a regular basis
Data collection on alcohol-related health indicators
System for monitoring alcohol-related harm
National treatment policy for alcohol use disorders
Persons with alcohol use disorders receiving treatment (%)
Designation of alcohol tax revenues to health services
National surveys on drink-driving
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
Community-based interventions/projects involving stakeholders
Interventions/projects actively involving young people and civil society
Training in screening and brief interventions for alcohol problems
Counselling to children in families with alcohol problems
Counselling to pregnant women with alcohol problems
Prevention/counselling at workplaces for those with alcohol problems
Advertising restrictions on social media
Restrictions on product placement in films/movies
Importance of measures for enhancing compliance with age limits
Government support for community action
Any community-based interventions involving stakeholders
National guidelines for implementing effective community-based interventions
National alcohol policy specifically involves young people activities
Penalties for drink driving
Sobriety checkpoints
Any detection of marketing infringements
Any penalties for marketing infringements
Price measures
Level of taxation adjusted for inflation
New types of alcoholic beverages emerging
Consumer information about calories, additives, etc on containers
Number of standard alcoholic drinks displayed on containers
Alcohol content displayed on containers
Action Plan for implementation of alcohol policy
Regional alcohol per capita (15+) consumption (in litres of pure alcohol)
Age-standardized heavy episodic drinking (population) past 30 days with 95%CI
Alcohol-attributable YLL score
Regional prevalence of alcohol dependence (%)
Regional prevalence of alcohol use disorders (%)
Total alcohol per capita (15+) consumption, projections to 2025
Recorded alcohol per capita (15+) consumption (in litres of pure alcohol), 3-year average with 95%CI
Unrecorded alcohol per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Total per capita (15+) consumption in litres of pure alcohol with 95%CI
Average daily intake in grams of alcohol among drinkers with 95%CI
Total alcohol per capita (15+) consumption, projected estimates for 2012
Age-standardized Alcohol use disorders (15+), 12 month prevalence (%) with 95%CI
Harmful use (15+), 12 month prevalence (%) with 95%CI
Percentage of children under 15 years exposed to second-hand smoke
Second-hand smoke attributable DALYs ('000) in children under 5 years
Second-hand smoke attributable DALYs per 100'000 children under 5 years
Percentage of women (15+ years) exposed to second-hand smoke
Percentage of men (15+ years) exposed to second-hand smoke
Second-hand smoke attributable deaths
Second-hand smoke attributable DALYs ('000)
Second-hand smoke attributable deaths per 100'000 capita
Second-hand smoke attributable DALYs per 100'000 capita
Second-hand smoke attributable deaths ('000) in children under 5 years
Second-hand smoke attributable deaths per 100'000 children under 5 years
Case detection rate for all forms of tuberculosis
Bacteriologically positive new pulmonary TB cases tested for MDR-TB (%)
Previously treated TB cases tested for MDR-TB (%)
Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
Laboratories providing drug susceptibility testing (DST) (per 5 million population)
Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
Treatment success rate for patients treated for MDR-TB (%)
Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
Tuberculosis - new and relapse cases
Total number of notified TB cases
Treatment success rate for retreatment tuberculosis cases
Confirmed cases of MDR-TB started treatment for MDR-TB (%)
Number of incident tuberculosis cases
Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
Number of incident tuberculosis cases, (HIV-positive cases)
Estimated MDR-TB cases among notified pulmonary TB cases
Number of deaths due to tuberculosis, excluding HIV
Number of prevalent tuberculosis cases
HIV-positive TB patients on ART (antiretroviral therapy) (%)
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
TB patients with known HIV status (%)
Tested TB patients HIV-positive (%)
Confirmed cases of MDR-TB
New cases: extrapulmonary
New cases: other
New cases: pulmonary smear-negative
New cases: pulmonary smear-positive
New cases: pulmonary smear unknown/not done
Other cases (treatment history unknown)
Retreatment cases: other
Retreatment cases: relapse (pulmonary smear and/or culture positive)
Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
Second-line drug susceptibility testing (DST) available
Current smoking of any tobacco product (age-standardized rate)
Current users of any tobacco product (youth rate)
Current smokers of cigarettes (youth rate)
Exposure to smoke at home
Exposure to smoke outside home
Year of survey of youth
Representativeness of youth survey
Repeating interval for survey of youth (years)
Total environment attributable deaths
Total environment attributable DALYs per 100'000 children under 5 years
% of deaths attributable to the environment in children under 5 years
% of DALYs attributable to the environment in children under 5 years
Total environment attributable deaths per 100'000 capita
Total environment attributable DALYs ('000)
Total environment attributable DALYs per 100'000 capita
% of deaths attributable to the environment
% of DALYs attributable to the environment
Total environment attributable deaths ('000) in children under 5 years
Total environment attributable deaths per 100'000 children under 5 years
Total environment attributable DALYs ('000) in children under 5 years
UV radiation
UV radiation attributable deaths
UV radiation attributable DALYs ('000)
UV radiation attributable deaths per 100'000 capita
UV radiation attributable DALYs per 100'000 capita
Anti-tobacco mass media campaigns
Do the health warnings on cigarette packaging include a photograph or graphic?
Do the health warnings on smokeless tobacco packaging include a photograph or graphic?
Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale?
Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale?
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health?
Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health?
Does the law mandate specific health warnings on cigarette packaging?
Does the law mandate specific health warnings on smokeless tobacco packaging?
How many health warnings are approved by the law for cigarette packaging?
How many health warnings are approved by the law for smokeless tobacco packaging?
Health warnings on cigarette packaging law requires or establishes fines for violations
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on cigarette packaging
Cigarette packaging and labeling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Smokeless tobacco packaging and labeling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Law mandates that health warnings appear on tobacco packages
Law mandates that health warnings appear on smokeless tobacco packages
Cigarette packaging and labeling must not use descriptors depicting flavors
Smokeless tobacco packaging and labeling must not use descriptors depicting flavors
Cigarette packaging and labeling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Smokeless tobacco packaging and labeling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
The quit line number must appear on cigarette packaging or labeling
The quit line number must appear on smokeless tobacco packaging or labeling
Plain packaging of cigarettes is mandatory (ie. the use of logos colors brand images or promotional information on packaging other than brand names and product names displayed in a standard color and font style is prohibited).
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colors brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Does the law mandate font style, font size and color of health warnings on cigarette packaging?
Does the law mandate font style, font size and color of health warnings on smokeless tobacco packaging?
Are the health warnings on cigarette packaging rotating?
Are the health warnings on smokeless tobacco packaging rotating?
Are the health warnings on cigarette packaging written in the principal language(s) of the country?
Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country?
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Life expectancy at birth (years)
Healthy life expectancy (HALE) at birth (years)
Neonatal mortality rate (per 1000 live births)
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
Infants exclusively breastfed for the first six months of life (%)
Children aged <5 years underweight (%)
Children aged <5 years overweight (%)
Adults aged ≥ 20 years who are obese (%)
Alcohol consumption among adults aged ≥15 years (litres of pure alcohol per person per year)
Stillbirth rate (per 1000 total births)
Life expectancy at age 60 (years)
Most recent census (year)
Civil registration coverage of cause-of-death (%)
Ill-defined causes in cause-of-death registration (%)
Distribution of years of life lost by broader causes (%)
Age-standardized mortality rate by cause (per 100 000 population)
Deaths due to HIV/AIDS (per 100 000 population)
Age-standardized mortality rate by cause (per 100 000 population) - Injuries
Age-standardized mortality rate by cause (per 100 000 population) - Noncommunicable
Distribution of years of life lost by broader causes (%) - Communicable
Distribution of years of life lost by broader causes (%) - Noncommunicable
Distribution of years of life lost by broader causes (%) - Injuries
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - All causes
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cancer
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cardiovasular disease and diabetes
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Chronic respiratory conditions
Age-standardized mortality rate by cause (per 100 000 population) - Communicable
Diphtheria - number of reported cases
Japanese encephalitis - number of reported cases
Pertussis - number of reported cases
Leprosy - number of reported cases
Total tetanus - number of reported cases
Meningitis - number of reported cases
Malaria - number of reported confirmed cases
Poliomyelitis - number of reported cases
Yellow fever - number of reported cases
H5N1 influenza - number of reported cases
Plague - number of reported cases
Mumps - number of reported cases
Congenital Rubella Syndrome - number of reported cases
Neonatal tetanus - number of reported cases
Rubella - number of reported cases
Measles - number of reported cases
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Children aged <5 years with ARI symptoms taken to a health facility (%)
Children aged <5 years with diarrhea receiving ORT (%)
Children aged <5 years with ARI symptoms who took antibiotic treatment (%)
Antenatal care coverage - at least one visit (%)
Antenatal care coverage - at least one visit, among girls aged 15-19 (%)
Births by caesarean section (%)
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Children aged 6-59 months who received vitamin A supplementation (%)
Neonates protected at birth against neonatal tetanus (PAB) (%)
Hib (Hib3) immunization coverage among 1-year-olds (%)
Antenatal care coverage - at least four visits (%)
Postnatal care visit within two days of birth (%)
BCG immunization coverage among 1-year-olds (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Population using improved drinking-water sources (%)
Population using improved sanitation facilities (%)
Population using solid fuels (%)
Median availability of selected generic medicines (%) - Private
Hospital beds (per 10 000 population)
Median consumer price ratio of selected generic medicines - Private
Private prepaid plans as a percentage of private expenditure on health
Per capita government expenditure on health at average exchange rate (US$)
Per capita total expenditure on health (PPP int. $)
Per capita government expenditure on health (PPP int. $)
General government expenditure on health as a percentage of total government expenditure
External resources for health as a percentage of total expenditure on health
Social security expenditure on health as a percentage of general government expenditure on health
Out-of-pocket expenditure as a percentage of private expenditure on health
Total expenditure on health as a percentage of gross domestic product
Private expenditure on health as a percentage of total expenditure on health
General government expenditure on health as a percentage of total expenditure on health
Per capita total expenditure on health at average exchange rate (US$)
Measles (MCV) immunization coverage among 1-year-olds (%)
Literacy rate among adults aged >= 15 years (%)
Population (in thousands) total
Net primary school enrolment ratio (%)
Population median age (years)
Population proportion under 15 (%)
Population living on <$1 (PPP int. $) a day (%)
Civil registration coverage of births (%)
Population proportion over 60 (%)
Gross national income per capita (PPP int. $)
Total fertility rate (per woman)
Population living in urban areas (%)
Annual population growth rate (%)
Crude birth rate (per 1000 population)
Crude death rate (per 1000 population)
Cellular subscribers (per 100 population)
Preterm birth rate (per 100 live births)
Water, sanitation and hygiene attributable deaths
Water, sanitation and hygiene attributable deaths ('000) in children under 5 years
Water, sanitation and hygiene attributable deaths per 100'000 capita
Water, sanitation and hygiene attributable deaths per 100'000 children under 5 years
Water, sanitation and hygiene attributable DALYs ('000)
Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years
Water, sanitation and hygiene attributable DALYs per 100'000 capita
Water, sanitation and hygiene attributable DALYs per 100'000 children under 5 years
Warn about the dangers of tobacco
Antenatal care coverage - at least one visit (in the two years preceding the survey) (%)
Antenatal care coverage - at least one visit (in the three years preceding the survey) (%)
Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)
Antenatal care coverage - at least four visits (in the x years preceding the survey) (%)
Antenatal care coverage - at least four visits (in the three years preceding the survey) (%)
Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)
Adolescent fertility rate (per 1000 women)
BCG immunization coverage among 1-year-olds (%)
Children aged <5 years with ARI symptoms taken to facility (%)
Contraceptive prevalence (modern methods) (%)
Contraceptive prevalence (modern and traditional methods) (%)
Births by caesarean section (in the three years preceding the survey) (%)
Births by caesarean section (in the five years preceding the survey) (%)
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Early initiation of breastfeeding (in the two years preceding the survey) (%)
Early initiation of breastfeeding (in the three years preceding the survey) (%)
Early initiation of breastfeeding (in the five years preceding the survey) (%)
Family planning needs satisfied (%)
Family planning needs satisfied (%)
Full immunization coverage among 1-year-olds (%)
Full immunization coverage among 1-year-olds (%)
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Children aged <5 years sleeping under insecticide-treated nets (%)
Children aged <5 years sleeping under insecticide-treated nets (%)
Pregnant women sleeping under insecticide-treated nets (%)
Pregnant women sleeping under insecticide-treated nets (%)
Measles (MCV) immunization coverage among 1-year-olds (%)
Measles (MCV) immunization coverage among 1-year-olds (%)
Prevalence of obesity in non-pregnant women aged 15 - 49 years, BMI >= 30 (%)
Prevalence of obesity in non-pregnant women aged 15 - 49 years, BMI >= 30 (%)
Children aged <5 years with diarrhea receiving oral rehydration therapy and continued feeding (%)
Children aged <5 years with ARI symptoms taken to facility (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Births attended by skilled health personnel (in the two years preceding the survey) (%)
Births attended by skilled health personnel (in the three years preceding the survey) (%)
Births attended by skilled health personnel (in the five years preceding the survey) (%)
Children aged <3 years stunted (%)
Children aged <5 years stunted (%)
Total fertility rate (per woman)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Children aged <3 years underweight (%)
Children aged <5 years underweight (%)
Children aged 6-59 months who received vitamin A supplementation (%)